Compass Therapeutics
NASDAQ: CMPX
Healthcare
Biotechnology
Rank
#18150
Market Cap
242.69 M
Volume
1.50 M
Price
1.76
Change (%)
3.85%
Country or region
United States
United States
Compass Therapeutics's latest marketcap:
242.69 M
As of May 8, 2025, Compass Therapeutics's market capitalization has reached $242.69 M. According to our data, Compass Therapeutics is the 18150th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 242.69 M |
| Revenue (ttm) | 850,000 |
| Net Income (ttm) | -49,375,000 |
| Shares Out | 138.28 M |
| EPS (ttm) | -0.36 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 20, 2025 |
Market Cap Chart
Data Updated: May 8, 2025
Compass Therapeutics's yearly market capitalization.
Compass Therapeutics has seen its market value drop from $308.98 M to $242.69 M since 2021, representing a total decrease of 21.46% and an annual compound decline rate (CAGR) of 6.95%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 8, 2025 | $242.69 M | 31% |
| December 31, 2024 | $199.50 M | 0.34% |
| December 29, 2023 | $198.83 M | -68.61% |
| December 30, 2022 | $633.47 M | 105.02% |
| December 31, 2021 | $308.98 M |
Company Profile
Frequently Asked Questions
As of May 8, 2025, Compass Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $242.69 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Compass Therapeutics global market capitalization ranking is approximately 18150 as of May 8, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2014 |
| IPO Date | n/a |
| Employees | 35 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
